A Randomized Trial Comparing Methotrexate and Vinblastine (MV) With Cisplatin, Methotrexate and Vinblastine (CMV) in Advanced Transitional Cell Carcinoma: Results and a Report on Prognostic Factors in a Medical Research Council Study

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1998.629
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-Vac) in Advanced Urothelial Cancer

Japanese Journal of Urology
Urology
1991English

Combination Chemotherapy for Advanced Urothelial Cancer With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-Vac)

Japanese Journal of Urology
Urology
1988English

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced and or Metastatic Bilharzial Urothelial Carcinoma of the Bladder in Egypt.

Research in Oncology
2011English

Co-Administration of Dexamethasone Increases Severity and Accelerates Onset Day of Neutropenia in Bladder Cancer Patients on Methotrexate, Vinblastine, Adriamycin and Cisplatin Chemotherapy: A Retrospective Cohort Study

Journal of Pharmaceutical Health Care and Sciences
2017English

Cisplatin, Vinblastine, and Bleomycin in Inoperable Non-Small Cell Lung Cancer.

Thorax
PulmonaryRespiratory Medicine
1985English

A Trial of Vinblastine Sulphate in the Treatment of Inoperable Carcinoma of the Lung.

British Journal of Cancer
Cancer ResearchOncology
1966English

Prognostic Factors and Outcomes of Primary Transitional Cell Carcinoma of the Ureter: A Population-Based Study

Oncotarget
Oncology
2017English

A Randomized Controlled Trial of Methotrexate for Patients With Generalized Myasthenia Gravis

Neurology
Neurology
2016English

Methotrexate and Actinomycin D Chemotherapy in a Patient With Porphyria: A Case Report

Journal of Medical Case Reports
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy